Rillieux-La-Pape, France

Corinne Beaulieu

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Rilleiux la Pape, FR (2017)
  • Rillieux la Pape, FR (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Corinne Beaulieu: Innovator in Microbiology and Cancer Diagnostics

Introduction

Corinne Beaulieu is a prominent inventor based in Rillieux-La-Pape, France. She has made significant contributions to the fields of microbiology and cancer diagnostics, holding a total of 8 patents. Her innovative methods have the potential to enhance the understanding and treatment of various diseases.

Latest Patents

One of her latest patents is a method for characterizing at least one microorganism by means of mass spectrometry. This method involves identifying microorganisms from a sample and determining their properties, including typing, potential resistance to antimicrobial agents, and virulence factors. The characterization is achieved through mass spectrometry, utilizing proteins, peptides, and metabolites as markers.

Another notable patent is a method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer. This invention relates to diagnosing colorectal cancer by detecting the presence of the Leukocyte Elastase Inhibitor tumor marker in biological samples from patients suspected of having the disease. This method can be instrumental for early diagnosis, screening, therapeutic follow-up, and prognosis.

Career Highlights

Corinne has worked with reputable organizations such as bioMérieux, Inc. and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to develop and refine her innovative techniques in microbiology and cancer diagnostics.

Collaborations

Throughout her career, Corinne has collaborated with notable colleagues, including Jean-Philippe Charrier and Dominique Rolland. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Corinne Beaulieu is a trailblazer in her field, with a focus on innovative methods that have the potential to revolutionize microbiology and cancer diagnostics. Her contributions are invaluable, and her work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…